Event Information:
Dates
March 17th to 19th, 2025
Location
Milan, Italy
Related Models
TransCure BioServices at BIO-Europe Spring 2025
We are pleased to announce that our CEO, Sebastien Tabruyn, will be attending BIO-Europe Spring 2025, taking place from March 17 to 19, 2025, in Milan, Italy.
As one of the most important partnering events for the biotech and pharma industries, BIO-Europe Spring brings together leading executives, investors, and innovators to foster collaborations and drive advancements in drug development.
At TransCure bioServices, we specialize in in vivo preclinical research using predictive humanized mouse models, providing biotech and pharma companies with cutting-edge in vivo solutions to de-risk and accelerate drug development in immuno-oncology, inflammatory/infectious diseases, and liver diseases.
📅 Looking to explore new preclinical strategies?
Book a meeting with Sebastien Tabruyn to discuss how our humanized mouse models can support your preclinical drug development programs.
👉 For more details about the event, visit: https://informaconnect.com/bioeurope-spring/
To book a meeting with Sébastien Tabruyn and discover how our humanized mouse models can accelerate your preclinical research:
Attending in person for TransCure BioServices:
Sebastien Tabruyn, PhD, CEO
Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). With over 20 years of experience as a Project Leader in worldwide academic research institutes, including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), Sebastien joined TransCure bioServices in 2013 to develop the first immune-oncology humanized mouse models. Before taking on the role of CEO, Sebastien served as the company’s Chief Scientific Officer for six years, where he was instrumental in driving scientific excellence and innovation. Sebastien Tabruyn has published more than 35 peer-reviewed publications, primarily focusing on oncology, inflammation, immunity, and angiogenesis. As CEO, Sebastien commits his leadership and vision to the expansion of TransCure bioServices through the successful delivery of its client needs.